192 related articles for article (PubMed ID: 23073047)
1. Anti-Rh(c), "little c," isoimmunization: the role of rHuEpo in preventing late anemia.
Zuppa AA; Cardiello V; Alighieri G; Cota F; D'Antuono A; Riccardi R; Catenazzi P; Romagnoli C
J Pediatr Hematol Oncol; 2013 Aug; 35(6):e269-71. PubMed ID: 23073047
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin in the prevention of late anemia in intrauterine transfused neonates with Rh-isoimmunization.
Zuppa AA; Alighieri G; Calabrese V; Visintini F; Cota F; Carducci C; Antichi E; Noia GA; Fortunato G; Romagnoli C
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e95-101. PubMed ID: 20216236
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness of recombinant human erythropoietin (EPO) treatment in a neonate with hyporegenerative anemia following Rh isoimmunization in spite of normal serum Epo level.
Erduran E; Bahadir A
Pediatr Hematol Oncol; 2011 Nov; 28(8):721-2. PubMed ID: 21875319
[No Abstract] [Full Text] [Related]
4. Erythropoietin as treatment for late hyporegenerative anemia in neonates with Rh hemolytic disease after in utero exchange transfusion.
Nicaise C; Gire C; Casha P; d'Ercole C; Chau C; Palix C
Fetal Diagn Ther; 2002; 17(1):22-4. PubMed ID: 11803211
[TBL] [Abstract][Full Text] [Related]
5. Hyporegenerative anemia associated with Rh hemolytic disease: treatment failure of recombinant erythropoietin.
Pessler F; Hart D
J Pediatr Hematol Oncol; 2002 Nov; 24(8):689-93. PubMed ID: 12439047
[TBL] [Abstract][Full Text] [Related]
6. Recombinant erythropoietin as treatment for the late hyporegenerative anemia of Rh hemolytic disease.
Ohls RK; Wirkus PE; Christensen RD
Pediatrics; 1992 Nov; 90(5):678-80. PubMed ID: 1408538
[TBL] [Abstract][Full Text] [Related]
7. Recombinant erythropoietin in the prevention of late anaemia in intrauterine transfused neonates with Rh-haemolytic disease.
Zuppa AA; Maragliano G; Scapillati ME; Florio MG; Girlando P; Noia G; De Santis M; Cavaliere AF; Romagnoli C; Tortorolo G
Fetal Diagn Ther; 1999; 14(5):270-4. PubMed ID: 10529568
[TBL] [Abstract][Full Text] [Related]
8. Late hyporegenerative anemia in neonates with rhesus hemolytic disease.
al-Alaiyan S; al Omran A
J Perinat Med; 1999; 27(2):112-5. PubMed ID: 10379500
[TBL] [Abstract][Full Text] [Related]
9. Management of late anemia in Rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study).
Ovali F; Samanci N; Dağoğlu T
Pediatr Res; 1996 May; 39(5):831-4. PubMed ID: 8726237
[TBL] [Abstract][Full Text] [Related]
10. Severe hemolytic disease of the newborn due to anti-Cw.
Byers BD; Gordon MC; Higby K
Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1180-2. PubMed ID: 16260563
[TBL] [Abstract][Full Text] [Related]
11. Haemolytic disease of the newborn caused by rhesus isoimmunization (anti-c).
Felc Z
East Mediterr Health J; 2001 Nov; 7(6):1065-9. PubMed ID: 15332750
[No Abstract] [Full Text] [Related]
12. Hyporegenerative anemia and other complications of rhesus hemolytic disease: to treat or not to treat is the question.
Alaqeel AA
Pan Afr Med J; 2019; 32():120. PubMed ID: 31223410
[TBL] [Abstract][Full Text] [Related]
13. Use of recombinant human erythropoietin (EPO-alfa) in a mother alloimmunized to the Js(b) antigen.
Santolaya-Forgas J; Vengalil S; Duval J; Gottmann D; Meyer W; Gauthier D; DeChristopher PJ
J Matern Fetal Med; 1999; 8(3):141-5. PubMed ID: 10338071
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin in human fetuses with immune hemolytic anemia and hydrops fetalis.
Moya FR; Grannum PA; Widness JA; Clemons GK; Copel JA; Hobbins JC
Obstet Gynecol; 1993 Sep; 82(3):353-8. PubMed ID: 8355933
[TBL] [Abstract][Full Text] [Related]
15. Management of isoimmunization in the presence of multiple maternal antibodies.
Spong CY; Porter AE; Queenan JT
Am J Obstet Gynecol; 2001 Aug; 185(2):481-4. PubMed ID: 11518913
[TBL] [Abstract][Full Text] [Related]
16. Severe Rh alloimmunization and hemolytic disease of the fetus managed with plasmapheresis, intravenous immunoglobulin and intrauterine transfusion: A case report.
Houston BL; Govia R; Abou-Setta AM; Reid GJ; Hadfield M; Menard C; Noyd J; Main S; Zarychanski R
Transfus Apher Sci; 2015 Dec; 53(3):399-402. PubMed ID: 26321100
[TBL] [Abstract][Full Text] [Related]
17. [Fetal plasma erythropoietin concentration during intrauterine transfusion therapy in isoimmunohemolytic anemia due to rhesus incompatibility].
Hebgen A; Schiffer-N'Gampolo D; Bald R; Hansmann M; Bode U
Ultraschall Med; 1997 Aug; 18(4):162-4. PubMed ID: 9381123
[TBL] [Abstract][Full Text] [Related]
18. Management of neonatal Rh disease.
Peterec SM
Clin Perinatol; 1995 Sep; 22(3):561-92. PubMed ID: 8521682
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of the fetus with Rh incompatibility by the combined methods of plasmapheresis and intrauterine blood transfusion].
Lozińska D; Radomska I; Samborska K; Dmoch E; Garwoliński J; Lenkiewicz B; Góralski T
Pol Tyg Lek; 1988 Nov; 43(45):1449-51. PubMed ID: 3151013
[No Abstract] [Full Text] [Related]
20. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
